Mountain View, CA, United States of America

Fenmei Yao

This inventor holds 33 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Prodrug Chemistry. Top assignees: Xenoport, Inc., Arbor Pharmaceuticals, LLC, Xero Port, Inc.. Active years: 2004-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fenmei Yao. Retrieved from https://idiyas.com/inventor/fenmei-yao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 (Patent Applications = 2)

% Patents Active = 42.4

CIPO Patents = 2

EPO Patents = 7 (Patent Applications = 5)

Average Co-Inventor Count = 5.2

ph-index = 10

Forward Citations = 358(Granted Patents)

Company Filing History:

Arbor Pharmaceuticals, LLC

Years Active: 2004-2019

Loading Chart...

Areas of Expertise:

Prodrugs

Acyloxyalkyl

Synthesis

GABA Analogs

Levodopa

Carbamate

Dimethyl-substituted

Cyclic Prodrugs

Crystalline Forms

Intermediates

Composition

Methods of Use

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10385014 - Acyloxyalkyl carbamate prodrugs, methods of synthesis and use (2019-08-20),

2. 9944592 - Acyloxyalkyl carbamate prodrugs, methods of synthesis and use (2018-04-17),

3. 9353057 - Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof (2016-05-31),

4. 8378137 - Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof (2013-02-19),

5. 8367722 - Methods of using prodrugs of pregabalin (2013-02-05),

6. 8324273 - Catechol protected levodopa diester prodrugs, compositions, and methods of use (2012-12-04),

7. 8324272 - Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use (2012-12-04),

8. 8258179 - Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use (2012-09-04),

9. 8168623 - Prodrugs of GABA analogs, compositions and uses thereof (2012-05-01),

10. 8143437 - Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof (2012-03-27),

11. 8062870 - Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs (2011-11-22),

12. 8048917 - Prodrugs of GABA analogs, compositions and uses thereof (2011-11-01),

13. 8003809 - Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof (2011-08-23),

14. 7872046 - Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use (2011-01-18),

15. 7868043 - Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use (2011-01-11),

Title: **Innovative Contributions of Fenmei Yao in Pharmaceutical Patents**

Introduction

Fenmei Yao, based in Mountain View, CA, has made significant strides in the field of pharmaceutical inventions, holding a remarkable total of 33 patents. His innovative work primarily revolves around prodrugs and their associated methods of synthesis and application, aimed at treating common diseases and disorders.

Latest Patents

Among his latest patents, Fenmei Yao has focused on acyloxyalkyl carbamate prodrugs, particularly those involving (±)-4-amino-3-(4-chlorophenyl)butanoic acid and its analogs. These patents cover the pharmaceutical compositions, methods of synthesis, and applications of these prodrugs for treating conditions such as spasticity and acid reflux disease. Additionally, these formulations are developed for oral administration and sustained release, representing significant advancements in drug delivery systems.

Career Highlights

Fenmei Yao's career includes notable tenures at companies renowned for their contributions to pharmaceutical development. He worked at Xenoport, Inc. and Xero Port, Inc., where he honed his expertise in drug formulation and patent applications. His extensive portfolio showcases his dedication to advancing medical solutions through innovative inventions.

Collaborations

Throughout his career, Fenmei Yao has collaborated with esteemed colleagues, including Mark A. Gallop and Jia-Ning Xiang. These partnerships have been instrumental in fostering innovation and the successful development of various pharmaceutical products.

Conclusion

Fenmei Yao stands out as a prolific inventor in the pharmaceutical industry, with a strong commitment to developing effective treatments through his patented innovations. His contributions not only enhance our understanding of drug formulations but also pave the way for future advancements in medical therapies.

Profile summary based on public USPTO records.